CLDF Title
Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
Live CME Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
HighwayRx   Banner2   Banner4   Banner3
 
             
  Liver News - REUTERS   Congress Calendar   Physician Resources  
 
 
Restricting fructose intake may reduce kids' liver fat accumulation
03-19-2015
Charity attacks Gilead over hepatitis C drug restrictions
03-18-2015
New market for liver disease spawns race for better testing
03-18-2015
Steroids for Graves' eye disease may boost risk of statin hepatotoxicity
03-18-2015
View Complete News Library
 
 
April 22-26
The International Liver Congress 2015, 50th annual meeting of the European Association for the Study of the Liver (EASL)
Vienna, Austria
May 2-6
AMERICAN TRANSPLANT CONGRESS
Philadelphia, Pennsylvania
May 6-9
48th ANNUAL MEETING- THE EUROPEAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION (ESPGHAN)
Amsterdam, Netherlands
May 16-19
DDW 2015
Washington, DC
View all Congresses
 
 
 
 
  Line  
  Featured Abstracts          
 
Virologic Response Following Combined Ledipasvir and Sofosbuvir Administration in Patients With HCV Genotype 1 and HIV Co-infection
 
Discovery and Development of Hepatitis C Virus Inhibitors Targeting the NS5A Protein
 
A Cross-Sectional Study Comparing the Frequency of Drug Interactions After Adding Simeprevir- or Sofosbuvir-Containing Therapy to Medication Profiles of Hepatitis C Monoinfected Patients
 
Ledipasvir/sofosbuvir regimens for chronic hepatits c (chc) infection: insights from a work productivity economic model from the United States
 
The hepatitis C genotype 1 paradox: Cost per treatment is increasing, but cost per cure is decreasing
 
Evaluation of two community-controlled peer support services for assessment and treatment of hepatitis C virus infection in opioid substitution treatment clinics: The ETHOS study, Australia
 
 
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies
 
Sharp truth: health care workers remain at risk of bloodborne infection
 
Prognosis in liver transplantation recipients after hepatitis B virus recurrence
 
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies
 
Chronic hepatitis C virus infection and neurological and psychiatric disorders: An overview
 
Presentation and complications associated with cirrhosis of the liver
 
 
Branched-chain amino acids for people with hepatic encephalopathy
 
Systematic review with network meta-analysis: the comparative effectiveness and safety of interventions in patients with overt hepatic encephalopathy
 
Surgical Treatment of Hepatocellular Carcinoma in North America: Can Hepatic Resection Still Be Justified?
 
Liver Transplantation for Hepatocellular Carcinoma
 
Tuberculosis reactivation in hepatocellular carcinoma: association with transarterial chemoembolization
 
Sorafenib or 90Y loaded resin microsphere radioembolization for locally-advanced hepatocellular carcinoma, what should we trust?
 
 
          View All Abstracts  
  Line  
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Live CME Meetings
Telewebs
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2015 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.